| Prev Close | 58.84 |
| Day Low/High | 59.12 / 60.55 |
| 52 Wk Low/High | 51.72 / 82.15 |
| Avg Volume | 8.25M |
CVS Health Corp. (CVS)
60.28
NYSE : Retail Trade
| Exchange | NYSE |
| Shares Outstanding | 1.30B |
| Market Cap | 76.52B |
| EPS | -0.60 |
| P/E Ratio | 16.57 |
| Div & Yield | 2.00 (3.42%) |
Latest News
Jim Cramer: In America, Lower Rates Are Nirvana for the Consumer and Stocks
Lower rates are terrible unless you spend money, buy goods, create businesses, refinance loans and basically exist in America.
China's Yuan Threat, Disney Volatility: Market Recon
The Chinese government has now demonstrated an ability to control the S&P 500, even at the risk of Chinese domestic capital flight.
Real Money Post-Industrial Average Leads Major Indexes So Far for Year
In July, the RMPIA climbed 0.6%, bringing its year-to-date return to just over 21%.
CBD Is Flexing on the Marijuana Industry
Be sure your cannabis investments have the right CBD strategy, as the market for these products takes off.
European Debt Markets, Uninverting Curve, Facebook's Libra, Trading Costco
This matters: Why the sudden 'weakness' across European debt markets?
Jim Cramer: Why Laggards Like Kohl's, Citi and CVS Can Rise Now
I am neutral on this market, and only a cool off of the hottest stocks can justify a further advance.
How 'Window Dressing' Can Hide the Losers
By selling out of big losers prior to the quarter's close, portfolio managers can hide the stocks from clients, but some downtrodden shares could be ripe for bounces next week, so here's my list.
Future Looks Healthy for CVS
CVS and Walgreens Boots Alliance make for good buys.
Real Money Post-Industrial Index Continues to Outperform Major Market Indices
Amid May's market turbulence, the RMPIA was buoyed by the more than 4% rise from Medtronic.
3 Managed Care Providers Are Finally Looking Promising on the Charts
A look at the charts and indicators of three big names in the sector .
Make Big Money: Think Like an Insider
Insider buying by corporate officers should be taken as optimistic visions of the future prospects of their companies and their stock prices.
Jim Cramer: With Biden the Democratic Favorite, These Stocks Are Front-Runners
These managed care stocks can withstand China, politics and a slowdown in the economy.
Real Money Post-Industrial Average Leaves Major Indices in the Dust
RMPIA outperformed once gain during April.
A Review of the Regulatory Hurdles Remaining for the CVS Aetna Acquisition
Aetna's additive effects on CVS's earnings might be front and center, but it isn't fully actualized just yet.
'Medicare for All' Efforts Should Rightfully Weigh on CVS Shareholder Minds
As CVS Health's stock continues to run, management's careful approach should be encouraging for beleaguered investors.
Here Are My Trade Ideas for CVS Stock
CVS Health is still a cash flow machine.
CVS Stock Surges as Aetna Acquisition Comes Into View
CVS is setting up an anticipated new stock trajectory for investors.
3 Top Healthcare Stocks Ripe For the Buying
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Chart of the Day: UNH's Universal Healthcare Comments Sting Sector
The free press that the progressive push for Medicare got on Tuesday morning is hurting the healthcare sector.
UnitedHealth Group Receives Booster Shot From Healthy Earnings, Outlook
The health benefit giant's fundamentals are good, but there are more symptoms to consider for a proper examination.
Jim Cramer: When the Death Star Strikes
It has become almost too onerous to own something that could be in Amazon's crosshairs.
Jim Cramer: Betting That the Next Pieces of News Will Be Very Stock Heartening
The consumer is alive, well, and might benefit from a thaw with China and easy to get jobs. So would Boeing and Caterpillar.
Tesla's Debacle and 3 More Stocks to Carefully Watch
Look at the entirety of your portfolio and make sure there are no earnings blow-ups coming from the companies that you own.
